Highlights

  • PetMed Express posted a quarterly loss of (0.41 USD) EPS, missing the 0.04 USD consensus estimate.
  • Shares traded at 3.60 USD, within a 12-month range of 1.57–5.58 USD, with market cap of 76.9M USD.
  • Institutional investors hold roughly 73% of PETS stock, showing high concentration of ownership.

PetMed Express (NASDAQ:PETS) announced quarterly earnings, reporting a loss of (0.41 USD) per share. This figure missed the consensus estimate of 0.04 USD by 0.45 USD. The company recorded a negative return on equity of 6.76% and a net margin of -2.76%, reflecting challenges in profitability during the period.

Wall Street Ratings
Analyst sentiment for PetMed Express remains cautious. The consensus price target stands at 3.20 USD. Recent analyst updates include a downgrade by Wall Street Zen from Hold to Sell, an upgrade by Zacks Research from Strong Sell to Hold, and Weiss Ratings maintaining a Sell rating.

Institutional Holdings Update
Several institutional investors modified their positions in PetMed Express during the quarter. Dimensional Fund Advisors LP increased its stake by 5.4%, holding 481,517 shares valued at 1.21M USD. Man Group plc added 7.1% more shares, totaling 151,039 shares worth 379K USD. Bridgeway Capital Management LLC grew its holdings by 164.3% to 107,816 shares valued at 271K USD. CIBC Bancorp USA initiated a position valued at 153K USD, and Goldman Sachs Group Inc. increased its stake by 59.3% to 33,209 shares worth 139K USD. Overall, institutional investors own approximately 73% of PETS shares.

Share Price Snapshot
The stock traded at 3.60 USD on the day of the earnings release. Its 12-month trading range spans from 1.57 USD to 5.58 USD. The company’s 50-day simple moving average is 2.34 USD, and the 200-day simple moving average is 2.89 USD. PetMed Express has a market capitalization of 76.93M USD and a price-to-earnings ratio of -12.00, with a beta of 0.75.